Search results
FDA Approves Almirall's Klisyri® (tirbanibulin) for the Treatment of Actinic Keratosis on Expanded...
Benzinga· 22 hours agoOriginal FDA approval (December 2020) now extended to the use of Klisyri on larger areas of the face or scalp (up to 100 cm2) to address more extensive manifestations of actinic keratosis, driving convenience for both
FDA Roundup: June 7, 2024
The Pilot News· 3 days agoToday, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the ...
Microbot’s LIBERTY robotic system secures FDA approval for pivotal trial
Medical Device Network via Yahoo Finance· 7 days agoThe trial is...surgeries related to endovascular procedures. It eliminates the need for large and...
...and Novel Linker Technology to Support Solid Tumor Antibody Radiation Conjugate Development at...
KOLR - KSFX Ozarks· 16 hours agoIomab-B led bone marrow transplant improved survival in patients with high-risk relapsed or refractory acute myeloid leukemia including those with a TP53 mutationIomab-B safely delivered < ...
University president dies after 3 year battle with sarcoma: What to know about rare cancer
USA Today· 14 hours agoMarquette University's president, Michael Lovell, died after battling a rare cancer for three years....
How Trump could upend vaccines
Politico· 14 hours agoRaskin and his colleagues argued in a letter to HHS Secretary Xavier Becerra that declaring an emergency would allow the FDA to take more action to address the shortages — ...
Health Care Week In Review: House Held Oversight Hearing on the 340B Program and HHS Expanded...
JD Supra· 1 day agoBelow is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance;...
NIAID funds second year of Pluri's radiation therapy studies By Investing.com
Investing.com· 4 days agoNational Institute of Allergy and Infectious Diseases (NIAID) to advance its cell therapy PLX-R18,...
EMA Grants Orphan Drug Designation to NeoImmuneTech's NT-I7 for the Treatment of Acute Radiation...
WWTI Watertown· 7 days agoROCKVILLE, Md. , June 4, 2024 /PRNewswire/ -- NeoImmuneTech, Inc. (NIT or "NeoImmuneTech"), a...
TikTok influencers claim sunscreen is harmful. Here's why that's wrong, and dangerous
Palm Beach Post via Yahoo News· 5 days agoAccording to the American Cancer...Administration report in 2020 that said some sunscreen...
